BRADLEY MYERS: Open Payments
NPI 1104293463 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,373 in 104 payments from 37 companies in 2025. Trend: 2023 $1,516 · 2024 $1,611 · 2025 $2,373
Food & beverage: $2,373
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $298 |
| AstraZeneca Pharmaceuticals LP | 7 | $140 |
| Merck Sharp & Dohme LLC | 6 | $137 |
| ABBVIE INC. | 6 | $131 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $122 |
| PFIZER INC. | 5 | $103 |
| E.R. Squibb & Sons, L.L.C. | 6 | $103 |
| Novartis Pharmaceuticals Corporation | 5 | $101 |
| Astellas Pharma US Inc | 5 | $100 |
| Exelixis Inc. | 5 | $95 |
Products named: RYBREVANT, KEYTRUDA, JOURNAVX, Enhertu, OPDIVO, Padcev, CABOMETYX, EPKINLY.
Industry payments across MS — which companies pay providers there.
